Loading...
XHKG
2120
Market cap84mUSD
May 09, Last price  
9.22HKD
1D
0.22%
1Q
-15.57%
Jan 2017
-72.88%
IPO
-81.22%
Name

Wenzhou Kangning Hospital Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
9.34
P/S
0.37
EPS
0.92
Div Yield, %
5.37%
Shrs. gr., 5y
0.09%
Rev. gr., 5y
13.96%
Revenues
1.65b
+3.63%
170,813,000226,363,000296,296,000343,674,000415,408,000666,435,528745,971,888860,691,7291,031,283,7601,297,430,3691,484,903,0421,596,265,5321,654,289,413
Net income
66m
-23.66%
13,231,00036,193,00051,198,00055,709,00068,832,00049,070,77480,595,67738,227,61855,770,16144,035,995085,947,80665,610,189
CFO
100m
-62.41%
22,608,00037,078,00033,328,000-5,063,00049,867,00081,498,91966,520,528111,289,774199,655,992193,896,498227,220,564265,033,23799,638,504
Dividend
Oct 16, 20240.16597 HKD/sh
Earnings
Aug 26, 2025

Profile

Wenzhou Kangning Hospital Co., Ltd. operates and manages a network of healthcare facilities in the People's Republic of China. It primarily focuses on providing psychiatric specialty care. The company also provides property leasing and sale services; and software and information technology services, as well as hospital management, forensic authentication, and medical services. It is also engaged in pharmaceutical retail. The company was formerly known as Wenzhou City Kangning Psychiatric Rehabilitation Hospital and changed its name to Wenzhou Kangning Hospital Co., Ltd. in October 2014. Wenzhou Kangning Hospital Co., Ltd. was founded in 1996 and is headquartered in Wenzhou, the People's Republic of China.
URL
http://www.knhosp.cn/
IPO date
Nov 19, 2015
Employees
4,652
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,654,289
3.63%
1,596,266
7.50%
1,484,903
14.45%
Cost of revenue
1,489,724
1,286,152
1,239,297
Unusual Expense (Income)
NOPBT
164,566
310,114
245,606
NOPBT Margin
9.95%
19.43%
16.54%
Operating Taxes
17,702
12,250
26,574
Tax Rate
10.76%
3.95%
10.82%
NOPAT
146,864
297,864
219,033
Net income
65,610
-23.66%
85,948
 
Dividends
(71,731)
(32,397)
Dividend yield
7.85%
3.22%
Proceeds from repurchase of equity
(21,278)
BB yield
2.11%
Debt
Debt current
320,270
335,666
252,016
Long-term debt
1,172,791
912,842
759,434
Deferred revenue
8,734
9,038
Other long-term liabilities
48,743
108,657
42,405
Net debt
1,087,205
618,125
533,692
Cash flow
Cash from operating activities
99,639
265,033
227,221
CAPEX
(192,179)
(179,732)
Cash from investing activities
(172,055)
(215,017)
Cash from financing activities
(76,917)
96,107
116,178
FCF
(138,250)
265,928
290,308
Balance
Cash
269,687
426,212
281,736
Long term investments
136,169
204,171
196,022
Excess cash
323,142
550,570
403,513
Stockholders' equity
575,644
529,698
432,425
Invested Capital
2,307,728
2,005,218
1,754,789
ROIC
6.81%
15.84%
12.51%
ROCE
6.26%
12.01%
11.17%
EV
Common stock shares outstanding
74,279
74,600
74,600
Price
12.30
-8.89%
13.50
 
Market cap
913,627
-9.28%
1,007,104
 
EV
2,121,121
1,768,370
EBITDA
322,390
423,664
359,817
EV/EBITDA
6.58
4.17
Interest
39,936
45,150
Interest/NOPBT
12.88%
18.38%